SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll is capturing significant market attention as traders rotate into established, meme-driven small caps, with the community actively rallying around its legacy as an original internet meme. Investors are highlighting the asset's cultural durability and momentum, frequently discussing it alongside other high-beta tokens as part of a broader shift in retail liquidity.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

Investors are actively discussing $RETIRE as a community-driven "last play" to replace traditional retirement funds, with many sharing stories of shifting capital from stagnant assets into this project. The community is highlighting the project's locked liquidity and active growth, framing it as a movement to achieve financial independence against current economic systems.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing active community debate as investors weigh the potential for institutional adoption following recent ETF filings against frustration over sluggish price action and technical challenges within its ecosystem. Supporters remain focused on utility-driven upgrades and long-term ecosystem expansion, while critics continue to voice skepticism regarding its market performance and historical promises.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as it gears up for a highly anticipated oral presentation of its pancreatic cancer data at the upcoming Digestive Disease Week conference. The community is buzzing with optimism, pointing to a recent string of clinical catalysts and trial expansions as key drivers for potential upward momentum.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and community speculation driven by its technical breakout attempts and active rotation into IoT, AI, and Japanese blockchain sector narratives. Traders remain sharply divided, with bulls pointing to ecosystem expansion and accumulation as the foundation for a potential run, while skeptics warn of volatility and continue to debate the project's long-term utility.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is currently the subject of intense community debate, with investors divided between bullish sentiment fueled by ETF speculation and potential ecosystem growth, and vocal frustration regarding persistent token dilution and stagnant price action relative to the broader market.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing intense community engagement as holders speculate on a massive breakout, fueled by comparisons to other memecoins and active discussions about its unique market narrative. While some traders are aggressively accumulating, others remain skeptical, leading to high volatility and polarizing sentiment across social channels.

ElizaOS

ElizaOS is currently at the center of intense debate, with some users highlighting its potential as an AI-agent operating system while a vocal portion of the community alleges widespread insider manipulation and fraudulent activity. Investors remain sharply divided, with some actively buying the dip in hopes of a long-term rally while others warn of deep structural corruption.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy is trending as investors weigh its robust global export demand and expansion projects against market volatility, with the community closely tracking its role in powering AI data centers and navigating the shifting natural gas landscape. The company remains a focal point for institutional interest and long-term positioning, particularly as traders scrutinize its long-term contract structures versus potential spot market opportunities.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is experiencing increased investor attention driven by a combination of strong demand for its AI server infrastructure and positive momentum from its recently completed Juniper Networks acquisition. The community is actively discussing the company's improved networking revenue, margin expansion potential, and its strategic positioning as a key beneficiary of the broader AI buildout alongside peers like Dell.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company’s outstanding shares will be reduced from roughly 929.5 million to around 18.6 million shares.</li><li>Kala Bio had until July 20, 2026, to regain compliance with Nasdaq’s minimum price requirement of $1 per share.</li><li>The Board of Directors had the option to effect a reverse stock split in a ratio ranging from 1-for-2 to 1-for-100.&nbsp;</li></ul>Shares of Kala Bio (KALA) plunged more than 27% to a record low on Thursday after the company announced a reverse stock split, following months of relentless decline that kept the stock from reclaiming the crucial $1 threshold even once this year.Kala Bio said it will implement a 1-for-50 reverse stock split, effective after the closing bell on May 8. The stock will begin trading on a split-adjusted basis on Nasdaq from May 11.Following the move, the company’s outstanding shares will be reduced from roughly 929.5 million to around 18.6 million shares.<h2 class="st-heading-2">KALA Shares Fell Below $1 In December 2025</h2>Kala Bio has until July 20, 2026, to regain compliance with Nasdaq’s minimum price requirement of $1 per share. It had received a notice from the exchange in January for failing to trade above the threshold for 30 straight business days between Dec. 3, 2025, and Jan. 16, 2026.Following the notice, the company held a special stockholder meeting on January 30, at which shareholders approved the Board of Directors’ authorization to effect a reverse stock split at a ratio of 1-for-2 to 1-for-100.<h2 class="st-heading-2">Retail Urges Buying The Dip</h2>Despite the intraday slump, retail sentiment on Stocktwits changed to ‘neutral’ from ‘bearish’ a day earlier.Chatter was largely positive, with one user stating that they would buy more shares.<stembedurl>https://stocktwits.com/7traderja/message/652575680</stembedurl><a href="https://stocktwits.com/symbol/KALA">KALA shares</a> have plummeted 86% so far this year.<h2 class="st-heading-2">‘Palantir For Biotech’</h2>Earlier this year, the company <a href="https://stocktwits.com/news-articles/markets/equity/why-did-kala-stock-surge-in-pre-market-today/cZdAxnCRIJk">unveiled</a> the Researgency.ai platform designed for biotech and pharmaceutical companies to help automate research and drug development tasks.It can support clinical trials, regulatory document management, drug safety tracking, and commercial launch preparation, the company said.“We are building the Palantir for biotech,” CEO Avi Minkowitz stated.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/atara-atra-stock-rises-fda-meeting-cancer-treatment/cZXbLfKReQ7">ATRA Stock Sees Biggest Single-Day Gain In Over 2 Years, Breaches Key Technical Milestone – New FDA Update Has Bulls Circling Back</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

KALA Stock Hits Record Low – Firm Announces Reverse Split After Shares Fail To Surpass The $1 Mark

Kala Bio said it will implement a 1-for-50 reverse stock split, effective after the closing bell on May 8.

Equity

KALA BIO (NASDAQ:KALA) Posts Quarterly Earnings Results

KALA BIO (NASDAQ:KALA - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.86 earnings per share (EPS) for the quarter...

KALA BIO, Inc. (NASDAQ:KALA) Sees Significant Drop in Short Interest

KALA BIO, Inc. (NASDAQ:KALA - Get Free Report) was the target of a large drop in short interest in March. As of March 31st, there was short interest totaling 1,137,572 shares, a drop of 83.3% from...

KALA BIO, Inc. (NASDAQ:KALA) Receives Consensus Rating of "Hold" from Analysts

KALA BIO, Inc. (NASDAQ:KALA - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are covering the firm, MarketBeat.com reports. One equities research...

KALA BIO, Inc. (NASDAQ:KALA) Short Interest Up 600.0% in March

KALA BIO, Inc. (NASDAQ:KALA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 6,830,724 shares...

KALA BIO (KALA) Projected to Post Quarterly Earnings on Thursday

KALA BIO (NASDAQ:KALA) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at...

KALA BIO, Inc. (NASDAQ:KALA) Short Interest Update

KALA BIO, Inc. (NASDAQ:KALA - Get Free Report) saw a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 975,765 shares, a growth...

AI Platforms, Data Infrastructure, and Healthcare Innovation Shape the Market Narrative

A fresh wave of developments across artificial intelligence, healthcare technology, and digital infrastructure is reinforcing a central theme dominating markets: the rapid convergence of AI with data-heavy industries. From biotech platforms deploying autonomous agents to data-center integrators scaling AI infrastructure, companies are positioning themselves to capture value from the next phase of the technology cycle. $KALA, $TGNT, $DOMO, $TSSI, $CYN, $AUNA, $VACHU

<ul class="summary-bullets"><li>Researgency enables firms to deploy AI tools for research, clinical trials, managing regulatory documents, and tracking drug safety.</li><li>Earlier this month, KALA signed a platform development and exclusive license agreement with Younet AI for Researgency.</li><li>The company said that while it will provide the AI platform, clients retain full control and ownership of their data.</li></ul>Shares of KALA BIO Inc. (KALA) shed most of their early gains to trade 25% higher on Wednesday, after the biotech company said it expects to ship its first commercial artificial intelligence product, the Researgency.ai platform, within 14 days.Researgency enables biotech and pharmaceutical companies to design and deploy AI tools to monitor research, support clinical trials, manage regulatory documents, track drug safety, and prepare commercial launch materials.The company said the platform is now fully live following a rebrand and is designed to deploy specialized AI agents to automate complex, repetitive tasks in drug development.“We are building the Palantir for biotech. Our first agent ships in 14 days, and our team is fired up. This is the beginning of something big,” said Avi Minkowitz, CEO of Kala.&nbsp;<h2 class="st-heading-2">Partnership With Younet AI To Develop Researgency</h2>Earlier this month, KALA signed a platform development and exclusive license agreement with Younet AI for Researgency. The agreement grants KALA access to the platform for an initial 12-month period, with the option to extend in one-year terms.KALA will provide the AI platform, specialized biomedical agents, and ongoing optimization, while clients retain full control and ownership of their data. The company said the platform targets small and mid-sized biotech firms seeking secure AI tools without relying on public AI services.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ zone over the past 24 hours, accompanied by ‘extremely high’ message volumes.&nbsp;<img src="https://news.stocktwits-cdn.com/KALA_jpg_f4e658a281.webp" alt="KALA.jpg">One user expects the stock to climb above $1 this week. It is currently at $0.36.<stembedurl>https://stocktwits.com/Ozunoy/message/647231891</stembedurl>Another user believes the development is “huge,” and that the company is “just getting started.”<stembedurl>https://stocktwits.com/jengtap/message/647229239</stembedurl><a href="https://stocktwits.com/symbol/KALA">KALA shares</a> have shed around 34% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-jumps-barclays-says-market-is-underestimating-opportunity-from-new-products/cZdr3RoRIJH">HIMS Stock Jumps 14% – Barclays Says Market Is Underestimating&nbsp;Opportunity From New Products</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

Why Did KALA Stock Surge 25% Today?

KALA BIO Inc company said that it is ready to deploy its new AI platform, Researgency, within 14 days.

The company said that it is ready to deploy its new AI platform, Researgency, within 14 days.

KALA BIO, Inc. (NASDAQ:KALA) Given Average Rating of "Hold" by Analysts

KALA BIO, Inc. (NASDAQ:KALA - Get Free Report) has been assigned a consensus rating of "Hold" from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. One...

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Kala Bio Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

KALA
KALA BIO Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest KALA News

KALAKALA BIO Inc